BIOMAT Database Logo BIOMAT Database Logo

[Prolonged neuromuscular block induced by mivacurium in a patient with acquired immunodeficiency syndrome]. 1998

M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D003473 Neuromuscular Nondepolarizing Agents Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. Curare-Like Agents,Curariform Drugs,Muscle Relaxants, Non-Depolarizing,Neuromuscular Blocking Agents, Competitive,Nondepolarizing Blockers,Agents, Curare-Like,Agents, Neuromuscular Nondepolarizing,Blockers, Nondepolarizing,Curare Like Agents,Drugs, Curariform,Muscle Relaxants, Non Depolarizing,Non-Depolarizing Muscle Relaxants,Nondepolarizing Agents, Neuromuscular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077590 Mivacurium An isoquinoline derivative that is used as a short-acting non-depolarizing agent. BW B1090U,BW-B 1090U,BW-B-1090U,BW-B1090U,Mivacron,Mivacurium Chloride,BW B 1090U,BWB 1090U,BWB1090U
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D019148 Neuromuscular Blockade The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. Neuromuscular Block,Block, Neuromuscular,Blockade, Neuromuscular

Related Publications

M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
[Prolonged neuromuscular block induced by mivacurium].
April 2006, Annales francaises d'anesthesie et de reanimation,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
[Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide].
January 1995, Annales francaises d'anesthesie et de reanimation,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Prolonged mivacurium-induced neuromuscular block.
July 1993, Anesthesia and analgesia,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Mivacurium-induced prolonged neuromuscular block.
February 1995, British journal of anaesthesia,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
[Prolonged neuromuscular block with mivacurium].
October 1997, Revista espanola de anestesiologia y reanimacion,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Prolonged mivacurium-induced neuromuscular block. Case report.
October 1999, Minerva anestesiologica,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Prolonged neuromuscular block with mivacurium in a patient with cholinesterase deficiency.
August 2000, Journal of the Formosan Medical Association = Taiwan yi zhi,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Prolonged neuromuscular block associated with mivacurium.
February 1995, British journal of anaesthesia,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Prolonged neuromuscular block after mivacurium.
January 1993, Anesthesia and analgesia,
M A López, and J Vilaplana, and M Obón Ferrer, and M A Fernández, and R Balanzá Roure, and S Soler Simón
Mivacurium and prolonged neuromuscular block.
September 1995, British journal of anaesthesia,
Copied contents to your clipboard!